Immune oncology, immune responsiveness and the theory of everything

Abstract Anti-cancer immunotherapy is encountering its own checkpoint. Responses are dramatic and long lasting but occur in a subset of tumors and are largely dependent upon the pre-existing immune contexture of individual cancers. Available data suggest that three landscapes best define the cancer...

Full description

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Tolga Turan, Deepti Kannan, Maulik Patel, J. Matthew Barnes, Sonia G. Tanlimco, Rongze Lu, Kyle Halliwill, Sarah Kongpachith, Douglas E. Kline, Wouter Hendrickx, Alessandra Cesano, Lisa H. Butterfield, Howard L. Kaufman, Thomas J. Hudson, Davide Bedognetti, Francesco Marincola, Josue Samayoa
Format: Article
Language:English
Published: BMJ Publishing Group 2018-06-01
Subjects:
Cancer immunotherapy
Checkpoint inhibitors
Immune resistance
Online Access:http://link.springer.com/article/10.1186/s40425-018-0355-5

Internet

http://link.springer.com/article/10.1186/s40425-018-0355-5

Similar Items